CLINICAL, ENDOSCOPIC, AND MICROBIOLOGICAL FEATURES OF CHRONIC RHINOSINUSITIS IN CHILDREN WITH CYSTIC FIBROSIS

Saodat Makhmudova; Nilyufar Khushvakova; Nargiza Khamrakulova

Авторы

Saodat Makhmudova First-Year Basic Doctoral (PhD) Student, Department of Otorhinolaryngology No. 1, Samarkand State Medical University. Автор
Nilyufar Khushvakova Head of the Department of Otorhinolaryngology No. 1, Samarkand State Medical University, Doctor of Medical Sciences, Professor. Автор
Nargiza Khamrakulova Associate Professor, Department of Otorhinolaryngology No. 1, Samarkand State Medical University, Doctor of Medical Sciences. Автор

Ключевые слова:

Cystic fibrosis

Аннотация

This article analyzes the clinical, endoscopic, and microbiological characteristics of chronic rhinosinusitis in children with cystic fibrosis. The major clinical manifestations, the diagnostic value of modern nasal endoscopy, and the predominant microorganisms isolated from sinonasal secretions are discussed. The role of microbiological investigations in guiding targeted antimicrobial therapy and the effectiveness of comprehensive treatment strategies are also evaluated. The findings suggest that early diagnosis and individualized management significantly improve disease control, reduce sinonasal inflammation, and contribute to better respiratory outcomes in children with cystic fibrosis.

##plugins.themes.default.displayStats.downloads##

##plugins.themes.default.displayStats.noStats##

Библиографические ссылки

1. Johnson B.J., Choby G.W., O'Brien E.K. Chronic rhinosinusitis in patients with cystic fibrosis—Current management and new treatments. Laryngoscope Investigative Otolaryngology. 2020;5(3):368–374.

2. Fokkens W.J., Lund V.J., Hopkins C., et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (EPOS 2020). Rhinology. 2020;58(Suppl S29):1–464.

3. Beswick D.M., Spielman D.B., Kimple A.J., et al. The Management of Cystic Fibrosis Chronic Rhinosinusitis: An Evidence-Based Review with Recommendations. International Forum of Allergy & Rhinology. 2022;12(9):1148–1183.

4. Krajewska J., Zub K., Słowikowski A., Zatoński T. Chronic rhinosinusitis in cystic fibrosis: A review of therapeutic options. European Archives of Oto-Rhino-Laryngology. 2022;279(1):1–24.

5. Orlandi R.R., Kingdom T.T., Hwang P.H., et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis 2021. International Forum of Allergy & Rhinology. 2021;11(3):213–740.

6. Cystic Fibrosis Foundation. Clinical Care Guidelines for Cystic Fibrosis. Bethesda, MD: Cystic Fibrosis Foundation; 2023.

7. Bell S.C., Mall M.A., Gutierrez H., et al. The future of cystic fibrosis care: A global perspective. The Lancet Respiratory Medicine. 2020;8(1):65–124.

8. Spielman D.B., Gudis D.A., Lee S., et al. Evidence-based management of chronic rhinosinusitis in cystic fibrosis. International Forum of Allergy & Rhinology. 2022;12(9):1148–1183.

9. Working Group on Pediatric Cystic Fibrosis. Working towards consensus in the management of pediatric chronic rhinosinusitis in cystic fibrosis. International Journal of Pediatric Otorhinolaryngology. 2020;135:110047.

10. Della Gatta B., Ronco L., Peradotto F., Bignamini E. Impact of elexacaftor/tezacaftor/ivacaftor on chronic rhinosinusitis in children with cystic fibrosis. European Respiratory Journal. 2023;62(Suppl 67):PA3380.